Permanent pacemakers in older persons

Journal of the American Geriatrics Society

Volumn 47, Issue 9, 1999, Pages 1125-1135

  Gregoratos, Gabriel ^a  

^a Stanford Medical Center Affiliate   (United States)

Author keywords

Atrioventricular block; Dual chamber; Pacemaker; Sinus node dysfunction

Indexed keywords

AGED; AGING; ARTICLE; ARTIFICIAL HEART PACEMAKER; ATRIOVENTRICULAR BLOCK; CARDIOMYOPATHY; COST EFFECTIVENESS ANALYSIS; GERIATRIC DISORDER; HEART ARRHYTHMIA; HEART INFARCTION; HUMAN; PRACTICE GUIDELINE; SINUS NODE DISEASE; TREATMENT INDICATION;

EID: 0032851679     PISSN: 00028614     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (74)

1. Kusumoto FM, Goldschlager N. Cardiac pacing. N Engl J Med 1996;334: 89-97.
2. Shen WK, Hammil SC, Hayes DL et al. Long-term survival after pacemaker implantation for heart block in patients over 65 years. Am J Cardiol 1994; 74:560-564.
3. Moss AJ, Hall WJ, Cannom DS et al. Improved survival with an implantable defibrillator in patients with coronary artery disease at high risk for ventricular arrhythmia. N Engl J Med 1996;335:1933-1940.
4. Amikam S, Lemer J, Roguin N et al. Long-term survival of elderly patients after pacemaker implantation. Am Heart J 1976;91:445-449.
5. Gregoratos G, Cheitlin MD, Conill A et al. ACC/AHA guidelines for implantation of cardiac pacemakers and antiarrhythmia devices: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Pacemaker Implantation). J Am Coll Cardiol 1998;31:1175-1209.
6. Lamas GA, Prosser AP, Edery TP et al. Age and sex bias in pacemaker selection. Circulation 1992;86: Suppl: 1-449.
7. Brown HF. Electrophysiology of the sinoatrial node. Physiol Rev 1982;62: 505-530.
8. Davies MJ, Pomerance A. Quantitative study of aging changes in the human sinoatrial node and internodal tracts. Br Heart J 1972;34:150-152.
9. Sims BA. Pathogenesis of atrial arrhythmias. Br Heart J 1972;34:336-340.
10. Fujino M, Okada R, Arakawa K. The relationship of aging to histological changes in the conduction system of the normal human heart. Jpn Heart J 1983;24:13-20.
11. Lenegre J. The pathology of complete atrioventricular block. Prog Cardiovasc Dis 1964;6:317-329.
12. Lev M. Anatomic basis for atrioventricular block. Am J Med 1964;37:742-746.
13. Edhag O, Swahn A. Prognosis of patients with complete heart block or arrhythmic syncope who were not treated with artificial pacemakers: A long-term follow-up study of 101 patients. Acta Med Scand 1976;200:457-463.
14. Donmoyer TL, DeSanctis RW, Austen WG. Experience with implantable pacemakers using myocardial electrodes in the management of heart block. Ann Thorac Surg 1967;3:218-227.
15. Barold SS. Indications for permanent cardiac pacing in first-degree AV block: Class I, II, or III? PACE 1966;19:747-751.
16. Mymin D, Mathewson FA, Tate RB, Manfreda J. The natural history of primary first-degree atrioventricular heart block. N Engl J Med 1986;315:1183-1187.
17. Brecker SJD, Xiao HB, Sparrow J, Gibson DG. Effects of dual chamber pacing with short atrioventricular delay in dilated cardiomyopathy. Lancet 1992;340:1308-1312.
18. Dhingra RC, Denes P, Wu D et al. The significance of second degree atrioventricular block and bundle branch block: Observations regarding site and type of block. Circulation 1974;49:638-646.
19. Strasberg B, Amat-Y-Leon F, Dhingra RC et al. Natural history of chronic second-degree atrioventricular nodal block. Circulation 1981;63:1043-1049.
20. Donoso E, Adler LN, Friedberg CK. Unusual forms of second-degree atrioventricular block, including Mobitz type-II block, associated with the Morgagni-Adams-Stokes syndrome. Am Heart J 1964;67:150-157.
21. Lamas GA, Pashos CL, Normand SLT et al. Permanent pacemaker selection and subsequent survival in elderly Medicare pacemaker recipients. Circulation 1995;91:1063-1069.
22. Bernstein AD, Parsonnet V. Survey of cardiac pacing in the United States. Am J Cardiol 1992;69:331-338.
23. Zion MM, Marchand PE, Obel IWP. Long term prognosis after cardiac pacing in atrioventricular block. Br Heart J 1973;35:359-364.
24. Alpert MA, Katti SK. The natural history of high-degree atrioventricular block following permanent pacemaker implantation. J Chronic Dis 1982;35: 341-344.
25. Scheinman MM, Peters RW, Sauve MJ et al. Value of the H-Q interval in patients with bundle branch block and the role of prophylactic permanent pacing. Am J Cardiol 1982;50:1316-1322.
26. Petrac D, Radic B, Birtic K et al. Prospective evaluation of intrahisian second degree AV block induced by atrial pacing in the presence of chronic bundle branch block. PACE 1996;19:784-792.
27. McAnulty JH, Rahimtoola SH, Murphy E et al. Natural history of "high-risk" bundle branch block: Final report of a perspective study. N Engl J Med 1982;307:137-143.
28. Denes P, Dhingra RC, Wu D et al. Sudden death in patients with chronic bifascicular block. Arch Intern Med 1977;137:1005-1010.
29. Linde-Edelstam C, Nordlander R, Pehrsson SK, Ryden L. A double-blind study of submaximal exercise tolerance and variation in paced rate in atrial synchronous compared to activity sensor modulated ventricular pacing. PACE 1992;15:905-915.
30. Gammage M, Schofield S, Rankin I et al. Benefit of single setting rate responsive ventricular pacing compared with fixed rate demand pacing in elderly patients. PACE 1991;14:174-180.
31. Andersen HR, Nielson JC, Thomsen PEB et al. Long term followup of patients from a randomized trial of atrial versus ventricular pacing for sick-sinus syndrome. Lancet 1997;305:1210-1296.
32. Stangl K, Seitz K, Wirtsfeld A et al. Differences between atrial single chamber pacing and ventricular single chamber pacing and antiarrhythmic effect in patients with sick sinus syndrome. PACE 1990;13:2080-2085.
33. Sgarbossa EB, Pinski SL, Maloney JD, et al. Chronic atrial fibrillation and stroke in paced patients with sick sinus syndrome: Relevance of clinical characteristics and pacing modalities. Circulation 1993;88:1045-1053.
34. Lamas GA, Orav J, Stambler B et al. Quality of life and clinical outcomes in elderly patients treated with ventricular pacing as compared with dualchamber pacing. N Engl J Med 1998;338:1097-1104.
35. Santini M, Ansalone G, Cacciatore G et al. Status of single chamber atrial pacing. In: Barold SS, Mujica J, eds. New Perspectives in Cardiac Pacing. Mt Kisco, NY: Futura Publishing Co, Inc., 1991, pp 273-301.
36. Rosenquist M, Aren C, Kristensson BE et al. Atrial rate-responsive pacing in sinus syndrome disease. Eur Heart J 1990;11:537-542.
37. Alboni P, Menozzi C, Brignole M et al. Effects of permanent pacemaker and oral theophyline in sick sinus syndrome. The THEOPACE study: A randomized controlled trial. Circulation 1997;96:260-266.
38. Peters RW, Scheinman MM, Morady F, Jacobson L. Long-term management of recurrent paroxysmal tachycardia by cardiac burst pacing. PACE 1985;8: 35-44.
39. Attuel P, Pellerin D, Mugica J, Coumel P. DDD pacing: An effective treatment modality for recurrent atrial arrhythmias. PACE 1988;11:1647-1654.
40. Saksena S, Prakash A, Hill M et al. Prevention of recurrent atrial fibrillation with chronic dual-site right atrial pacing. J Am Coll Cardiol 1996;28:687-694.
41. Saksena S, Pantopoulos D, Parsonnet V et al. Usefulness of an implantable antitachycardia pacemaker system for supraventricular or ventricular tachycardia. Am J Cardiol 1986;58:70-74.
42. Barold SS, Wyndham CR, Kappenberget LL et al. Implanted atrial pacemakers for paroxysmal atrial flutter: Long-term efficacy. Ann Intern Med 1987; 107:144-149.
43. Eldar M, Griffin JC, Abbott JA et al. Permanent cardiac pacing in patients with the long QT syndrome. J Am Coll Cardiol 1987;10:600-607.
44. Eldar M, Griffin JC, Van Hare GF et al. Combined use of beta-adrenergic blocking agents and long-term cardiac pacing for patients with the long QT syndrome. J Am Coll Cardiol 1992;20:830-837.
45. Moss AJ, Robinson J. Clinical features of the idiopathic long QT syndrome. Circulation 1992;85(Suppl I):140-144.
46. Naccarelli GV, Dougherty AH, Jala S et al. Paroxysmal supraventricular tachycardia: Comparative role of therapeutic methods - drugs, devices and ablation. In: Saksena S, Luderitz D, eds. Interventional Electrophysiology: A Textbook. Armonk, NY: Futura Publishing Co, Inc., 1996, pp 381-390.
47. Daubert C, Mabo P, Berder V. Arrhythmia prevention by permanent atrial resynchronization in advanced intratrial block. Eur Heart J 1990;11:237-242.
48. Sra JS, Jazayeti MR, Avitall B et al. Comparison of cardiac pacing with drug therapy in the treatment of neurocardiogenic (vasovagal) syncope with bradycardia or asystole. N Engl J Med 1993;328:1085-1090.
49. Sugrue DD, Gersh BJ, Holmes DR et al. Symptomatic 'isolated' carotid sinus hypersensitivity. Natural history and results of treatment with anticholinergic drugs or pacemaker. J Am Coll Cardiol 1986;7:158-162.
50. Peretz DI, Gerein AN, Miyagishima RT. Permanent demand pacing for hypersensitive carotid sinus syndrome. Can Med Assoc J 1973;68:1032-1036.
51. Brignole M, Menozzi C, Gianfranchi L et al. Neurally mediated syncope detected by carotid sinus massage and head-up tilt test in sick sinus syndrome. Am J Cardiol 1991;68:1032-1036.
52. Benditt DG, Ferguson DW, Grubb BP et al. Tilt table testing for assessing syncope. J Am Coll Cardiol 1996;8:263-275.
53. Kenny RA, Ingram A, Bayliss J et al. Head-up tilt: A useful test for investigating unexplained syncope. Lancet 1986;1:1352-1355.
54. Fitzpatrick A, Sutton R. Tilting towards a diagnosis in recurrent unexplained syncope. Lancet 1989;1:658-660.
55. Connoly SJ, Sheldon R, Roberts RS et al. The North American Vasovagal Pacemaker Study (VPS). A randomized trial of permanent cardiac pacing for the prevention of vasovagal syncope. J Am Coll Cardiol 1999;33:16-20.
56. McDonald K, McWilliams E, O'Keeffe B, Maurer B. Functional assessment of patients treated with permanent dual chamber pacing as a primary treatment for hypertrophic cardiomyopathy. Eur Heart J 1988;9:893-898.
57. Fananapazir L, Epstein ND, Curiel RV et al. Long-term results of dual-chamber (DDD) pacing in obstructive hypertrophic cardiomyopathy; Evidence for progressive symptomatic and hemodynamic improvement and reduction of left ventricular hypertrophy. Circulation 1994;90:2731-2742.
58. Fananapazir L, Cannon RO, Tripodi D, Panza JA. Impact of dual-chamber permanent pacing in patients with obstructive hypertrophic cardiomyopathy with symptoms refractory to verapamil and beta-adrenergic blocker therapy. Circulation 1992;85:2149-2161.
59. Cannon RO, Tripodi D, Dilsizian V et al. Results of permanent dual chamber pacing in symptomatic nonobstructive hypertrophic cardiomyopathy. Am J Cardiol 1994;73:571-576.
60. Nishimura RA, Trusty JM, Hayes DL et al. Dual-chamber pacing for hypertrophic cardiomyopathy: A randomized, double-blind, crossover trial. J Am Coll Cardiol 1997;29:435-341.
61. Nishimura RA, Hayes DL, Holmes DR, Tajik AJ. Mechanism of hemodynamic improvement by dual-chamber pacing for severe left ventricular dysfunction: An acute Doppler and catheterization hemodynamic study. J Am Coll Cardiol 1995;25:281-288.
62. Hochleitner M, Hortnagl H, Fridrich L, Gschnitzer F. Long-term efficacy of physiologic dual-chamber pacing in the treatment of end-stage idiopathic dilated cardiomyopathy. Am J Cardiol 1992;70:1320-1325.
63. Auricchio A, Sommariva L, Salo RW et al. Improvement of cardiac function in patients with severe congestive heart failure and coronary artery disease by dual chamber pacing with shortened AV delay. PACE 1993;16:2034-2043.
64. Linde C, Gadler F, Edner M et al. Results of atrioventricular synchronous pacing with optimized delay in patients with severe congestive heart failure. Am J Cardiol 1995;75:919-923.
65. Gold MR, Felician Z, Gottlieb SS, Fisher ML. Dual-chamber pacing with a short atrioventricular delay in congestive heart failure: A randomized study. J Am Coll Cardiol 1995;26:967-973.
66. DiBiase A, Tse TM, Schnittger I et al. Frequency and mechanism of brady-cardia in cardiac transplant recipients and need for pacemakers. Am J Cardiol 1991;67:1385-1389.
67. Heinz G, Hirschl M, Buxbaum P et al. Sinus node dysfunction after orthotopic cardiac transplantation: Postoperative incidence and long-term implications. PACE 1992;15:731-737.
68. Scott CD, Dark JH, McComb JM. Sinus node function after cardiac transplantation. J Am Coll Cardiol 1994;24:1334-1341.
69. Scott CD, Omar I, McComb JM et al. Long-term pacing in heart transplant recipients is usually unnecessary. PACE 1991;14:1792-1796.
70. Montero JA, Anguita M, Concha M et al. Pacing requirements after orthotopic heart transplantation: Incidence and related factors. J Heart Lung Transplant 1992;11:799-802.
71. Payne ME, Murray KD, Watson KM et al. Permanent pacing in heart transplant recipients: Underlying causes and long-term results. J Heart Lung Transplant 1991;10:738-742.
72. Grinstead WC, Smart FW, Pratt CM et al. Sudden death caused by brady-cardia and asystole in a heart transplant patient with coronary arteriopathy. J Heart Lung transplant 1991;10:931-936.
73. Bernstein AD, Camm AJ, Fletcher RD et al. The NASPF/BPEG generic pacemaker code for antibradyarrhythmia and adaptive-rate pacing and antitachyarrhythmia devices. PACE 1987;10:794-799.
74. Crossley GH, Gayle DD, Simmons TW et al. Reprogramming pacemakers enhances longevity and is cost-effective. Circulation 1996;94(suppl II):245-247.